Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

In vivo and in vitro evidence that Tc-99m-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-014-2764-0
Purpose Recent advances in basic science have established that inflammation plays a pivotal role in the pathogenesis of atherosclerosis. Inflammatory cells are thought to be responsible for the transformation of a stable plaque into a vulnerable one. Lymphocytes constitute at least 20 % of infiltrating cells in these vulnerable plaques. Therefore, the interleukin-2 (IL-2) receptor, being overexpressed on activated T lymphocytes, may represent an attractive biomarker for plaque vulnerability. The aim of this study was to evaluate the specificity of radiolabelled IL-2 [Tc-99m-hydrazinonicotinamide (HYNIC)-IL-2] for imaging the lymphocytic...
Andor W. J. M. Glaudemans, Elena Bonanno, Filippo Galli, Clark J. Zeebregts, Erik de Vries, Michel Koole, Gert Luurtsema, Hendrikus H. Boersma, Maurizio Taurino, Riemer H. J. A. Slart, Alberto Signore
Cardiac diphosphonate uptake
Published in: Heart
Access to document 10.1136/heartjnl-2013-305465
Walter Noordzij, Andor W. J. M. Glaudemans, Riemer H. J. A. Slart, Bouke P. C. Hazenberg
Cushingoid facies on (18)F-FDG PET/CT
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-014-2762-2
Ronald W. J. van Rheenen, Andor W. J. M. Glaudemans, Sabine L. A. Plasschaert, Walter Noordzij, Riemer H. J. A. Slart
Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis
Published in: Amyloid: Journal of protein folding disorders
Access to document 10.3109/13506129.2014.881796 document
Walter Noordzij, Andor W J M Glaudemans, Ronald W J van Rheenen, Rudi A Dierckx, Riemer H J A Slart, Bouke P C Hazenberg
Residual estrogen receptor availability during fulvestrant 500 mg therapy in patients with metastatic breast cancer.
Michel van Kruchten, Elisabeth G. E. de Vries, Myles Brown, Andor W. J. M. Glaudemans, Meta C. van Lanschot, Ido P. Kema, Martijn Van Faassen, Carolien P. Schroder, Erik F. J. De Vries, Geke Hospers